AstraZeneca (AZN) Q4 results beats analyst expectations.Revenues: $7,410M (+11%); Product Sales: $7,011M (+12%); Collaboration Revenue: $399M (-4%).Total Revenue included $2M of…
https://seekingalpha.com/news/3661074-astrazeneca-tops-q4-forecast-c19vaz-sales-of-2m

